What happened
Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and consumption in a small trial involving people with moderate alcohol use disorder, researchers reported Wednesday in the journal JAMA Psychiatry. It was the first randomized controlled trial to study the effects of semaglutide on alcohol addiction, though anecdotal evidence and observational and animal studies have suggested the drug curbs desire for alcohol as well as food.
Who said what
The federally funded study gave 48 adults with signs of alcohol use disorder small doses of either semaglutide or a placebo once a week for nine weeks. Those receiving the semaglutide shots consumed significantly less alcohol on the days they drank versus the control group, though both groups drank about the same number of days each week.
"We hoped to see a reduction in drinking and craving," said study lead author Dr. Christian Hendershot of the USC Institute for Addiction Science. But the "magnitude of the effects" was unexpectedly good compared to the three little-used FDA-approved medications for alcohol use disorder. Semaglutide is already popular, and the finding that it helped people drink less could boost treatment uptake, addiction psychiatrist Dr. Raymond Anton said to CNN. "Most people seeking treatment do not want a goal of abstinence for the rest of their lives."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What next?
Several larger studies are underway on semaglutide and alcohol, plus the drug's effects on "smokers, people with opioid addiction and cocaine users," The Associated Press said. It's unclear how safe semaglutide "would be for a person of normal weight."
-
September 27 editorial cartoonsCartoons Saturday's political cartoons include Donald Trump and the rapture that wasn't
-
Sarah Ferguson: a reputation in tattersIn the Spotlight After emails surfaced revealing ties to Jeffrey Epstein, weeks after she claimed to cut contact, her charities are running for the hills
-
Sudoku medium: September 27, 2025The Week's daily medium sudoku puzzle
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
The battle of the weight-loss drugsTalking Point Can Novo Nordisk and Eli Lilly regain their former stock market glory? A lot is riding on next year's pills
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Food may contribute more to obesity than exerciseUnder the radar The devil's in the diet
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Is that the buzzing sound of climate change worsening sleep apnea?Under the radar Catching diseases, not those ever-essential Zzs
-
Deadly fungus tied to a pharaoh's tomb may help fight cancerUnder the radar A once fearsome curse could be a blessing
